Insider · CIK 0002156820
Richard Thomas Menziuso
Files at ALT (Altimmune, Inc.). First filing -, latest -.
Richard Thomas Menziuso files SEC Form 4 as officer at ALT (Altimmune, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard Thomas Menziuso has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +84,546 | $0.00 | $0 | 84,546 | 11 d ago |
| Oct 1, 2026 | ALT Altimmune, Inc. | AGrant or award Restricted Stock Unitsderivative | +36,234 | $0.00 | $0 | 36,234 | 11 d ago |
Questions about Richard Thomas Menziuso
Answered from the filings on this page, as of the latest one.
Is Richard Thomas Menziuso buying or selling?
Richard Thomas Menziuso has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard Thomas Menziuso's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Thomas Menziuso has 0.
Where does Richard Thomas Menziuso file Form 4?
Richard Thomas Menziuso has filed Form 4 at ALT (Altimmune, Inc.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.